Moolec Science SA
Change company Symbol lookup
Select an option...
MLEC Moolec Science SA
GDHG Golden Heaven Group Holdings Ltd
VOD Vodafone Group PLC
PGY Pagaya Technologies Ltd
NUZE NuZee Inc
MFC Manulife Financial Corp
NXPL NextPlat Corp
ELEV Elevation Oncology Inc
CTLP Cantaloupe Inc
QH Quhuo Ltd
Go

Consumer Staples : Food Products |
Based in Luxembourg
Company profile

Moolec Science SA is a science-based food ingredient company. The Company focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. It operates in the United States, Europe, and South America. The Company's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.

Closing Price
$2.91
Day's Change
0.209 (7.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.91
Day's Low
2.70
Volume
(Average)
Volume:
4,601

10-day average volume:
4,460
4,601

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Marathon Digital Holdings, Inc. (MARA) on Behalf of Investors

10:00 am ET March 17, 2023 (BusinessWire) Print

Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of Marathon Digital Holdings, Inc. ("Marathon" or the "Company") (NASDAQ: MARA) investors concerning the Company's possible violations of the federal securities laws.

If you suffered a loss on your Marathon investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Marathon-Digital-Holdings-Inc-1/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On February 28, 2023, Marathon announced that it was unable to timely file its fourth quarter and full year 2022 financial results and would reissue financial statements dating back to 2021 after an inquiry conducted by the SEC flagged several accounting errors.

On this news, Marathon's stock price fell $0.59, or 8.3%, to close at $6.51 per share on March 1, 2023, thereby injuring investors.

Then, on March 16, 2023, after market hours, Marathon released its fourth quarter and fiscal year 2022 financial results, reporting a net loss of $686.7 million for 2022.

On this news, Marathon's stock price fell during after-hours trading on March 16, 2023, thereby injuring investors further.

Follow us for updates on LinkedIn, Twitter, or Facebook.

Whistleblower Notice: Persons with non-public information regarding Marathon should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@glancylaw.com.

About GPM

Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. ISS Securities Class Action Services has consistently ranked GPM in its annual SCAS Top 50 Report. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM's nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM's lawyers have handled cases covering a wide spectrum of corporate misconduct including cases involving financial restatements, internal control weaknesses, earnings management, fraudulent earnings guidance and forward looking statements, auditor misconduct, insider trading, violations of FDA regulations, actions resulting in FDA and DOJ investigations, and many other forms of corporate misconduct. GPM's attorneys have worked on securities cases relating to nearly all industries and sectors in the financial markets, including, energy, consumer discretionary, consumer staples, real estate and REITs, financial, insurance, information technology, health care, biotech, cryptocurrency, medical devices, and many more. GPM's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230317005067/en/

SOURCE: Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com 
shareholders@glancylaw.com
comtex tracking

COMTEX_426862515/1006/2023-03-17T10:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.